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Audrey G.H. Janssen,4 Ahmad U. Zafar,3 Ute Scholl,4 Tayyab Husnain,3 Inna A. Belyantseva,1
Penelope L. Friedman,5 Sheikh Riazuddin,3 Thomas B. Friedman,1 and Christoph Fahlke4,6,*
BSND encodes barttin, an accessory subunit of renal and inner ear chloride channels. To date, all mutations of BSND have been shown to
cause Bartter syndrome type IV, characterized by signiﬁcant renal abnormalities and deafness.We identiﬁed a BSNDmutation (p.I12T) in
four kindreds segregating nonsyndromic deafness linked to a 4.04-cM interval on chromosome 1p32.3. The functional consequences of
p.I12T differ from BSND mutations that cause renal failure and deafness in Bartter syndrome type IV. p.I12T leaves chloride channel
function unaffected and only interferes with chaperone function of barttin in intracellular trafﬁcking. This study provides functional
data implicating a hypomorphic allele of BSND as a cause of apparent nonsyndromic deafness. We demonstrate that BSND mutations
with different functional consequences are the basis for either syndromic or nonsyndromic deafness.Antenatal Bartter syndrome comprises a genetically and
phenotypically heterogeneous group of salt-losing ne-
phropathies.1,2 Affected individuals with Bartter syndrome
type IV (MIM 602522) suffer from increased urinary
chloride excretion, elevated plasma renin activity, hyperal-
dosteronism, and hyperprostaglandinuria as well as senso-
rineural deafness. Typically, this disorder manifests in the
second gestational trimester with the development of
prenatal renal salt wasting, polyhydramnios, premature
delivery, nephrocalcinosis, and life-threatening volume
depletion in the neonate.3–5
We ascertained Pakistan families segregating nonsyn-
dromic deafness with IRB approval at the National Insti-
tutes of Health and at the University of the Punjab. We
mapped DFNB73 to chromosome 1p32 in a genome-wide
linkage analysis of families PKDF393 and PKDF606 by
using 388 ﬂuorescently labeled microsatellite markers
(STRs) spaced an average of 10 cM apart (ABI Prism Linkage
Mapping Set, v2.5 Applied Biosystems). Subsequently, we
screened ~700 Pakistani families by using STRs in the
DFNB73 linkage interval and found two additional families
segregating deafness (PKDF067 and PKDF815) linked to
DFNB73. The four DFNB73-linked families were further
genotyped with STR markers in the 1p32 region (Figures
1 and 2). Meiotic breakpoint information deﬁned an
interval of 4.04 cM containing 26 predicted and annotated
genes, and among them was BSND (MIM #606412;
NM_057176.2) encoding barttin.6 We PCR-ampliﬁed and
sequenced the four exons of BSND from affected members
of the four DFNB73 families that were analyzed in this
study. Three of these families, PKDF393, PKDF606, andThe AmerPKDF067, were found to be segregating the c.35T>C allele
ofBSND resulting in a substitution of threonine for a highly
conserved isoleucine (p.I12T) (Figure 2B). In a fourth
family, PKDF815, 25 affected members enrolled in this
study. Twenty-two affected individuals are homozygous
for the c.35T>C (p.I12T) mutation, and three (VI:15,
VI:16, and VI:17) are compound heterozygotes [c.35T>C
(p.I12T)/c.10G>T (p.E4X)] (Figure 1B). We did not detect
carriers of either mutation in 384 chromosomes from Pak-
istani hearing control individuals.
We obtained a detailed clinical history for each affected
individual to determine the neonatal course, any develop-
mental delays, signs of polyuria, polydipsia, and salt
craving. For all affected individuals, we performed a phys-
ical examination to evaluate motor skills, body weight,
stature, and morphology and determined serum and
urinary chemistry values to deﬁne aspects of metabolic
and renal function. We performed renal sonography to
determine the presence or absence of nephrocalcinosis.
On a selected number of affected individuals of the
DFNB73 families, we conducted an audiometric evaluation
by measuring the threshold of hearing at 250–8000 Hz for
pure-tone air conduction and bone conduction.
All affected members of families PKDF393, PKDF606,
and PKDF067 are deaf, but did not show other signs or
symptoms of Bartter syndrome type IV. They were born
from full-term pregnancies with reportedly normal birth
weight and length. Polyhydramnios was not identiﬁed
during gestation. Nor have the affected individuals dis-
played problems with polydipsia, polyuria, nocturnal
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Figure 1. Mutations of BSND Result in Nonsyndromic and Syndromic Hearing Loss in Family PKDF815
(A) Affected individuals V:15-17, V:19, and VI:2-5 have distal and proximal breakpoints at D1S2661 and D1S475, respectively, deﬁning
the smallest linkage interval to ~4 cM. Individuals VI:15-17 are segregating prelingual profound deafness along with elevated renin and
nephrocalcinosis (Table 1).
(B) Electropherograms of amplimers from genomic DNA templates illustrate homozygosity for the c.35T>C mutant allele among
affected family members segregating isolated hearing loss. Affected family members segregating deafness along with nephrocalcinosis
and elevated renin are compound heterozygous for c.35T>C and c.10G>T.retardation, or signs of developmental delay. The com-
pound heterozygous (p.I12T/p.E4X) members of family
PKDF815 manifest nephrocalcinosis, elevated renin levels,
and electrolyte levels, suggesting borderline, not clinically
signiﬁcant metabolic alkalosis and hypokalemia (Table 1,
and Table S1 available online). Homozygous p.I12T indi-
viduals display elevated renin levels and hypocalciuria,
but neither metabolic alkalosis nor nephrocalcinosis.
Audiometric evaluation showed severe hearing loss
across all frequencies, without differences among homozy-
gotes for p.I12T and compound heterozygotes (p.I12T/
p.E4X) (Figure S1). These data indicate that homozygosity
for p.I12T results in hearing loss. However, p.I12T in
combination with a likely loss-of-function nonsense muta-
tion, p.E4X, additionally leads to mild, asymptomatic
metabolic abnormalities, in agreement with a partial loss
of function of p.I12T barttin. For mutations of BSND, our
data in combination with published reports indicate that
there is a wide phenotypic continuum fromnonsyndromic
deafness with elevated renin of uncertain clinical signiﬁ-
cance to salt-losing nephropathies.3–6
Barttin is an accessory subunit of two human ClC-K
channels, ClC-Ka (MIM #602024) and ClC-Kb (MIM274 The American Journal of Human Genetics 85, 273–280, August#602023), that are essential for chloride reabsorption along
the distal nephron and for endolymph formation in the
inner ear.7–13 Barttin promotes exit of ClC-K channels
from the endoplasmic reticulum,7,8,10 increases protein
stability,9 and converts human ClC-K channels from a
nonconducting into an active state.10 We used heterolo-
gous expression in mammalian cells to test for impair-
ments of these functions by p.I12T.
We coexpressed wild-type (WT) or mutant p.I12T barttin
with human ClC-Ka or ClC-Kb in HEK293T cells and
measured anion currents through patch-clamp record-
ings10,12 (Figure 3). In cells expressing ClC-Ka or ClC-Kb
together with barttin, anion currents can be observed
over the whole voltage range without time-dependent
current relaxations (Figures 3A and 3C). Untransfected
HEK293Tcells or cells that express ClC-Ka, ClC-Kb, or bart-
tin alone exhibit negligible currents under the same ionic
conditons.10,12 Current amplitudes in cells expressing
ClC-Ka/ClC-Kb channels together with p.I12T barttin are
smaller than corresponding values for WT barttin, for stan-
dard internal and external [Cl] (Figures 3B and 3D) as well
as for reduced intra- and extracellular anion concentra-
tions (Figure S2). The effect of p.I12T on ClC-Ka/barttin14, 2009
Figure 2. A Highly Conserved Isoleucine Residue of Barttin when Mutated Causes Nonsyndromic Hearing Loss, DFNB73
(A) Pedigrees of three Pakistani families cosegregating nonsyndromic hearing loss with genetic markers linked to DFNB73. Affected
members of all three pedigrees are homozygous for the p.I12T mutant allele of BSND. The unaffected members are homozygous or
heterozygous for the wild-type allele. All obligate carriers are heterozygous.
(B) Amino acid sequence alignment of barttin orthologs for the amino terminus. Identical residues are colored in black. The isoleucine
residue at the 12th position is conserved among a variety of species.
(C) Haplotype analysis on chromosome 1p32.3 in affected members of the four families (PKDF067, PKDF393, PKDF606, and PKDF815).
For each SNP, the distance on the physical map is provided (UCSC genome browser, March 2006 assembly). The p.I12 allele resides
between SNPs rs2500341 and rs34561276. Homozygotes for p.I12T share a common haplotype. Further SNP genotyping of the affected
members of the four families that were homozygous for p.I12T conﬁrmed that these families carry a common ancestral haplotype in the
region surrounding the mutation, whereas the p.E4X mutation arose on a different haplotype.currents (ratio of mean current amplitudes at 100 mV ¼
24%) is more pronounced than for ClC-Kb/barttin (ratio
of mean current amplitudes at 100 mV ¼ 44%).The AmerTo distinguish whether p.I12T affects the function or the
intracellular trafﬁcking of ClC-K/barttin channels, we per-
formed single-channel recordings and noise analysis. Inican Journal of Human Genetics 85, 273–280, August 14, 2009 275
Table 1. Clinical and Biochemical Features of Wild-Type, Carriers, and Compound Heterozygotes of Family PKDF815
Family Members
Features Reference Ranges V:22 V:23 VI:14 VI:15 VI:16 VI:17 VI:18
Genotypes Ta/þ Xb/þ þ/þ X/T X/T X/T X/þ
Present age (y) 53 40 17 20 16 19 24
Hearing loss hearing hearing hearing deaf deaf deaf hearing
Other symptoms of BSIVc no no no no no no no
Sd Na (mmol/L) 136–148 138 143 143 139 141 141 137
S K (mmol/L) 3.6–5.0 4.6 4.0 4.8 3.5 3.6 3.5 4.2
S Cl (mmol/L) 104–114 105 107 106 98 102 103 102
S HCO3 (mmol/ L) 17.5–27.5 27.1 31.0 27.4 29.5 29.5 31.2 26.8
S Mg (mg/dl) 1.9–2.5 2.1 2.4 2.3 2.2 2.0 2.1 2.2
S Ca (mg/dl) 8.6–10.5 8.7 8.9 9.7 9.4 10.1 9.8 9.2
S Creatinine (mg/dl) 0.85–1.35 0.9 0.6 0.9 0.7 0.5 0.6 0.9
Pe Renin (ng/ml/hr) 0.15–2.33 0.199 0.29 5.22 11.64 23.42 12.74 0.83
S Aldosterone (ng/dl) 1–16;f 4–31 3.2 >1.1f 12.0 11.5 12.0 4.2 5.8
S Osmolality (mosm/Kg) 275–295 289 294 287 283 285 284 284
Ug Na (mmol/L) 30–150 32.9 15.5 152.2 37.5 17.3 12.5 65.3
U K (mmol/L) 20–67 9.44 2.5 94.66 11.95 6.33 3.22 28.41
U Cl (mmol/L) 46–168 37.0 14.2 176.1 49 18.2 10.3 76.8
U Mg (mg/dl) 2.1 0.8 22.4 3.8 2.8 1.1 6.5
U Ca (mg/dl) 2.0 <2.0 13.0 6.5 1.5 <2.0 7.4
U osmolality (mosm/Kg) 50–1400 186 70 891 187 103 53 308
Nephrocalcinosis absent absent absent present present present absent
a p.I12T.
b p.E4X.
c Other symptoms of BSIV are polyhydramnion, premature birth, low birth weight, failure to thrive, polyuria, polydipsia, and nocturnal enuresis.
d ‘‘S’’ denotes serum.
e ‘‘P’’ denotes plasma.
f There are two normative values for serum aldosterone: 1–16 ng/dl for blood drawn while the patient is supine and 4–31 ng/dl for blood drawn while the patient
is standing.
g Urinary (U) values were determined from spot samples.agreement with the double-barreled structure of ClC chan-
nels,14 we observed two equally spaced subconductance
states with a unitary conductance of 26 pS in patches
expressing ClC-Ka/barttin (Figures 3E and 3F). Channels
were open most of the time at positive potentials, whereas
at negative potentials short open and short closed times re-
sulted in a fast ﬂickering behavior (Figure 3E). Ten out of
twenty-onepatches fromcells expressingClC-Ka/WTbarttin
containedchannelswithunitaryconductancesandgatingas
shown in Figure 3E. Such channels were neither observed in
12 patches from untransfected cells nor in 37 patches from
cells expressingV166E rClC-K1.10 In cells expressing ClC-Ka
and p.I12T barttin, we observed channels with properties
identical to those of ClC-Ka/WT barttin channels in 11 out
of 85 patches. Remaining patches either lacked single-
channel events or contained endogenous channels. Hence,
unitary currents of ClC-Ka/p.I12T barttin were indistin-
guishable from ClC-Ka/WT barttin (Figures 3E and 3F).276 The American Journal of Human Genetics 85, 273–280, AugustTo conﬁdently assign unitary channels observed in
patch-clamp experiments to macroscopic ClC-Ka/barttin
currents, we additionally employed a variation of sta-
tionary noise analysis (Figure S3).15–18 Steady-state vari-
ances were determined at voltages between 85 mV and
205 mV, divided by the product of the mean current
amplitudes and the electrical driving force (V  Vr), and
plotted against the macroscopic conductance (Figures
S3B–S3D). The slope (1N) of the ﬁtted straight gives the
number of channels N, and the y axis intercept provides
the unitary conductance. Experiments were performed
for two different anion compositions, and for both ionic
conditions the unitary conductances of ClC-Ka/barttin
channels were not different for WT and p.I12T barttin
(Figure S3E). The number of channels was 8800 5 2190
(n ¼ 8) in cells transfected with WT barttin, whereas cells
expressing p.I12T barttin contained only 3232 5 1048
channels (n ¼ 8). We next determined absolute open14, 2009
AB D F
C E
Figure 3. Functional Consequences of p.I12T on ClC-K/Barttin Channel Activity
(A–D) Representative recordings and current-voltage relationships of macroscopic currents from HEK293T cells coexpressing ClC-Ka (A
and B) or ClC-Kb (C and D) and wild-type (WT) or p.I12T barttin with standard internal and external solutions. Whole-cell and single-
channel patch-clamp recordings were performed with an Axopatch 200B ampliﬁer (Molecular Devices).10,17 The extracellular solution
contained 140mMNaCl, 4 mMKCl, 2mMCaCl2, 1 mMMgCl2, and 5mMHEPES (pH 7.4), whereas the intracellular solution contained
120mMNaCl, 2mMMgCl2, 5mMEGTA, and 10mMHEPES (pH 7.4). The voltage dependence of instantaneous current amplitudes was
determined with voltage steps (8–10ms) from a holding potential of 0 mV so that potentials between200 toþ200mV could be tested.
Data points represent means5 SEM from between 16 and 26 cells.
(E and F) Representative single-channel recordings (E) and unitary current-voltage relationships (F) of ClC-Ka/barttin channels forWTor
p.I12T barttin. Single-channel recordings were either performed in the inside-out conﬁguration, with pipettes containing the standard
extracellular solution and cells bathed in the standard intracellular solution, or in the cell-attached conﬁguration with cells bathed in the
standard extracellular solution and the pipettes containing a modiﬁed bath solution with 140 mMKCl, 4 mMNaCl, 2 mMCaCl2, 1 mM
MgCl2, and 5mMHEPES (pH 7.4). Currents were sampled at 50 kHz and ﬁltered at 500–1000 Hz. Because of the high open probability of
ClC-Ka/barttin channels, unitary current amplitudes were manually determined from channel closures that exceeded 5 ms. Data points
represent means5 SEM from three to ten measurements.probabilities from macroscopic current amplitudes (I),
unitary current amplitudes (i), and the number of channels
(N) as p ¼ I/Ni. Absolute open probabilities change with
anion concentrations but are not different for ClC-Ka/
WT barttin and ClC-Ka/p.I12T barttin (Figure S3F). In
single-channel recordings as well as in noise analysis,
ClC-Ka/p.I12T barttin channels displayed unaltered prop-
erties as compared to ClC-Ka/WTbarttin channels (Figure 3
and Figure S3). Thus, the p.I12T mutation has no effect on
permeation or gating of ClC-Ka/barttin channel but only
reduces the number of channels in the surface membrane.
We were not able to determine unitary properties of ClC-
Kb/barttin channels. These channels appear to be voltage
independent, precluding noise analysis for determining
unitary current amplitudes and absolute open probabili-
ties. Moreover, we could not reliably identify unitary
events in single-channel recordings. We therefore deter-
mined ratios of the current variance (s2) and the macro-
scopic current amplitude (I). This value is identical to the
product of the unitary current amplitude and the absolute
probability of the channel to be closed (s2/I ¼ i(1  p)).17The AmerFor all tested voltages, values are similar for ClC-Kb/WT
barttin (s2/I ¼ 0.03 5 0.007 pA; n ¼ 9, at 105 mV)
and ClC-Kb/p.I12T barttin (s2/I ¼ 0.027 5 0.006 pA;
n ¼ 7, at 105 mV), in agreement with the notion that
p.I12T also leaves ClC-Kb/barttin channel function unaf-
fected.
To test whether these reduced current levels are due to
reduced protein expression levels, we resolved YFP- and
CFP-fusion proteins from cells expressing YFP-ClC-Ka or
YFP-ClC-Kb together with CFP-labeled WTor mutant bart-
tin, on reducing SDS-PAGE.12 We electrophoresed cleared
lysates from transfected HEK293T cells on 6%–15% SDS
polyacrylamide gradient gels and quantiﬁed CFP- or YFP-
tagged proteins by scanning wet PAGE gels with a ﬂuores-
cence scanner (Typhoon, GE Healthcare). We observed
comparable expression levels for CFP-WT barttin and
CFP-p.I12T barttin as well as for YFP-ClC-Ka and YFP-ClC-
Kb coexpressed with WT or mutant barttin (Figure 4A).
We conclude that p.I12T leaves protein amounts of pore-
forming and accessory subunits of ClC-K/barttin channels
unaffected.ican Journal of Human Genetics 85, 273–280, August 14, 2009 277
A B Figure 4. p.I12T Neither Affects the
Number of Expressed ClC-K Channels
nor the Glycosylation Status
(A) Fluorescent protein expression levels
from HEK293T cells coexpressing WT or
p.I12T barttin-CFP with YFP-ClC-Ka or
YFP-ClC-Kb. For each experiment, SDS-
PAGE gels (6%–15%) were prepared from
the lysates of whole dishes of comparable
cell number and transfection efﬁciency.
Fluorescence was quantiﬁed with the
ImageQuant software and normalized to
corresponding ﬂuorescence levels from
cells coexpressing WT barttin. Data repre-
sent means 5 SEM from eight or nine
measurements.
(B) SDS-PAGE gel (6%–15%) of YFP-ClC-Ka
or YFP-ClC-Kb either transfected alone or cotransfected with WT or mutant barttin in MDCKII cells shows complex-glycosylated (#) as
well as core-glycosylated (C) or not glycosylated () protein. The lower panel shows ratio of complex-glycosylated to total YFP-ClC-Ka
and YFP-ClC-Kb ﬂuorescence from cells coexpressing WT or mutant barttin. Mean5 SEM is from three or more experiments. Asterisks
indicate levels of signiﬁcance (**p < 0.01 or *p < 0.05) for comparison with cells without barttin. Glycosylation levels were not different
for cells expressing WT or p.I12T barttin.To study channel trafﬁcking, we used MDCKII cells, an
established model for intracellular protein trafﬁcking in
epithelial cells, instead of HEK293T cells.9,10,12 WT barttin
is necessary for export of ClC-K/barttin out of the endo-
plasmic reticulum.10,12 ClC-K channels are N-glycosylated
in eukaryotic cells, and the presence of complex oligosac-
charides can be used for monitoring the efﬁciency of the
exit of the protein from the ER.12 p.I12T does not impair
complex glycosylation of ClC-Ka or ClC-Kb, indicating
normal ER exit (Figure 4B). We next studied the subcellular278 The American Journal of Human Genetics 85, 273–280, Augustdistribution of WT and p.I12T barttin and ClC-K by using
confocal imaging of cells expressing ﬂuorescent fusion
proteins (Figure 5). MDCKII cells transfected with expres-
sion plasmids encoding barttin-CFP and YFP-ClC-Ka or
YFP-ClC-Kb were scanned as living cells 1–3 days after
transfection with a FluoView 1000 (Olympus) equipped
with an argon-ion laser and a 603 objective with a NA of
1.35. CFP and YFP were excited with the 458 and 514 nm
argon lines and photometrically detected with Olympus
ﬁlters BA465-495 and BA535-565,19 respectively. WhenA B C
Figure 5. Subcellular Distribution of WT and Mutant Barttin
Fluorescent confocal images of living MDCK cells expressing WT or p.I12T mutant barttin-CFP fusion proteins either alone (A) or
together with YFP ClC-Ka (B) or YFP ClC-Kb (C). The scale bar represents 5 mm. CFP is shown in green, and YFP is shown in red. There
is an orange color where both proteins overlap.14, 2009
expressed alone, WT as well as p.I12T barttin insert them-
selves into the plasma membrane (Figure 5A). For WT and
mutant barttin, colocalization of YFP and CFP ﬂuorescence
conﬁrmed surface localization and effective binding of
ClC-Ka and ClC-Kb with barttin (Figures 5B and 5C). Cells
expressing p.I12T exhibit increased ﬂuorescent staining of
intracellular compartments, in agreement with impaired
surface insertion of p.I12T barttin and ClC-K/p.I12T
barttin. We conclude that p.I12T impairs late steps in traf-
ﬁcking of barttin and ClC-K/barttin.
Lack of either one of the two ClC-K isoforms impairs
urinary concentration, but not hearing.11,20 These results
indicate that in the inner ear, only one isoform is required
and suggest that one ClC-K isoform can compensate for
a genetic defect of the other one. In contrast, moderate
impairment of the chaperone function of barttin by
p.I12T causes nonsyndromic deafness. These ﬁndings
demonstrate that barttin performs a rate-limiting step in
ClC-K channel maturation. In the presence of dysfunc-
tional barttin, the inner ear is more sensitive to a reduction
in chloride conductances than the kidney. Moreover,
p.I12T appear to have less pronounced effects on macro-
scopic current amplitudes of ClC-Kb/barttin than of ClC-
Ka/barttin (Figure 3), and the residual ClC-Kb activity in
kidney might contribute to the preserved renal function.
Several disease-causing BSNDmutations have been iden-
tiﬁed and functionally analyzed. In all cases, there is a
genotype-phenotype relationship in that the level of func-
tion of mutant barttin predicts the renal phenotype.12
Whereas nonsense mutations result in a pronounced renal
phenotype,6 mutations that were identiﬁed in patients
with late-onset or mild deterioration of the renal
system5,21 have milder effects on barttin function than
mutations causing early-onset renal symptoms.12 A small
but signiﬁcant reduction in ClC-K/barttin currents by
p.I12T barttin selectively causes a hearing impairment,
whereas there is a borderline renal salt-reabsorption deﬁcit
in compound heterozygotes p.12T/E4X. Our ﬁndings
demonstrate that a pathogenic mutation of BSND can
cause deafness with subclinical renal metabolic changes
and thus deﬁnes BSND as a causal gene in nonsyndromic
deafness DFNB73.
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